Olivia Ware has served as our director since April 2021. She has more than 20 years of pharmaceutical drug development, commercialization, and healthcare management experience, with a history of successful commercial drug launches including Rituxan®, Herceptin®, Avastin® and Lucentis®. In addition to drug development, Olivia has experience in developing managed care, pricing, and contract strategy, developing marketing programs for field-based sales teams, and establishing, growing, and optimizing organizations for long-term success. Previously, Olivia was the Senior Vice President, BTK Franchise Head at Principia Biopharma Inc., where she was responsible for developing portfolio strategy for the company’s three BTKi molecules. Prior to that, she served as Senior Vice President, U.S. Market and Franchise Development at Proteus Digital Health, Inc., was Chief Commercial Officer at CytRx, Inc., and held various leadership roles at Genentech, Inc.
Olivia is also an independent board member at Revance Therapeutics where she serves on the Nomination and Governance and the Science and Technology Committees.
Olivia graduated from Davidson College and received her MBA from the University of North Carolina at Chapel Hill. She is now President of the Davidson College Board of Visitors and a member of the Davidson Board of Trustees.